BE856355A - Procede pour combattre les infections virales - Google Patents

Procede pour combattre les infections virales

Info

Publication number
BE856355A
BE856355A BE178982A BE178982A BE856355A BE 856355 A BE856355 A BE 856355A BE 178982 A BE178982 A BE 178982A BE 178982 A BE178982 A BE 178982A BE 856355 A BE856355 A BE 856355A
Authority
BE
Belgium
Prior art keywords
viral infections
fight viral
fight
infections
viral
Prior art date
Application number
BE178982A
Other languages
English (en)
Inventor
B F H Eriksson
A J E Helgstrand
A Misiorny
G B Stening
S-A A Stridh
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE856355(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of BE856355A publication Critical patent/BE856355A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE178982A 1976-07-01 1977-07-01 Procede pour combattre les infections virales BE856355A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (1)

Publication Number Publication Date
BE856355A true BE856355A (fr) 1978-01-02

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
BE178982A BE856355A (fr) 1976-07-01 1977-07-01 Procede pour combattre les infections virales

Country Status (22)

Country Link
US (4) US4215113A (fr)
JP (1) JPS536428A (fr)
AT (1) AT369014B (fr)
AU (1) AU510809B2 (fr)
BE (1) BE856355A (fr)
BG (1) BG60834B2 (fr)
CA (1) CA1077848A (fr)
CH (1) CH641471A5 (fr)
DE (1) DE2728685C2 (fr)
DK (1) DK288877A (fr)
FI (1) FI772030A (fr)
FR (1) FR2356424A1 (fr)
GB (1) GB1585615A (fr)
HK (1) HK28984A (fr)
IE (1) IE45753B1 (fr)
LU (2) LU77666A1 (fr)
MX (1) MX9203635A (fr)
MY (1) MY8500125A (fr)
NL (2) NL180068C (fr)
NO (1) NO772299L (fr)
SE (1) SE7607496L (fr)
SG (1) SG80383G (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
CA1140049A (fr) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Substances pharmaceutiques obtenues a partir de derives d'acide hydroxycarbonylphosphonique
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPS59500317A (ja) * 1982-02-12 1984-03-01 シンテツクス　（ユー・エス・エイ）　インコーポレイテツド 抗ウイルス性組成物
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
AU5014285A (en) * 1985-10-21 1987-05-05 Sergio, W. Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
CA2223874A1 (fr) * 1995-06-06 1996-12-12 The University Of Southern California Procedes et compositions servant a inhiber la replication du cytomegalovirus
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1603542A1 (fr) * 2003-03-14 2005-12-14 Epistem Limited Traitement et/ou prevention d'une deterioration epitheliale non virale
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
US20090214676A1 (en) 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) * 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (fr) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Formes galéniques transmucosales du foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
JPS536428A (en) 1978-01-20
US4215113A (en) 1980-07-29
ATA465477A (de) 1982-04-15
NL180068C (nl) 1987-01-02
AU510809B2 (en) 1980-07-17
AT369014B (de) 1982-11-25
US4771041A (en) 1988-09-13
SG80383G (en) 1984-08-03
IE45753B1 (en) 1982-11-17
DK288877A (da) 1978-01-02
DE2728685A1 (de) 1978-01-12
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
LU77666A1 (fr) 1977-10-07
LU88310I2 (fr) 1994-05-04
NL930053I2 (nl) 1994-01-03
DE2728685C2 (de) 1982-09-16
FI772030A (fr) 1978-01-02
NL7707235A (nl) 1978-01-03
SE7607496L (sv) 1978-01-02
CH641471A5 (de) 1984-02-29
NO772299L (no) 1978-04-25
NL930053I1 (nl) 1993-09-01
BG60834B2 (bg) 1996-04-30
CA1077848A (fr) 1980-05-20
AU2650577A (en) 1979-01-04
FR2356424B1 (fr) 1980-04-18
GB1585615A (en) 1981-03-11
MX9203635A (es) 1992-09-01
NL180068B (nl) 1986-08-01
FR2356424A1 (fr) 1978-01-27
US4665062A (en) 1987-05-12
US4339445A (en) 1982-07-13
JPS562046B2 (fr) 1981-01-17
MY8500125A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
BE856355A (fr) Procede pour combattre les infections virales
BE855273A (fr) Procede de preparation de polyurethannes
BE857854A (fr) Procede de preparation de polyurethanne-urees
RO76054A (fr) Procede pour la preparation des tetradecapeptides
FI792365A (fi) Membran med poroes yta
RO70854A (fr) Procede pour la preparation des metha-aryloxybenzaldehydes
BE858640A (fr) Procede pour la preparation de methoxypsoralene
RO70462A (fr) Procede pour la preparation des 3-halomethylcephem
RO71572A (fr) Procede pour la preparation des oxycarbamates n-sulphenyles
RO71066A (fr) Procede pour la preparation des 2-chlorsulfinylazetidin-4-ones
RO72900A (fr) Procede pour la preparation des cis-4a-phenyloctahydro-1h-2-pyrindines
BE853162A (fr) Procede de preparation de chloromethylsilanes
RO72831A (fr) Procede pour la preparation des fenilpyperazines
BE860699A (fr) Procede de preparation de gamma-pyrones
RO70052A (fr) Procede pour la preparation des 7-alcoxy-3-chloremethylecephemes
FR2340057A1 (fr) Procede de solidification des melasses
FR2301610A1 (fr) Procede pour la protection
FR2343725A1 (fr) Procede de preparation de methallyl-sulfonate de sodium
RO71742A (fr) Procede pour la preparation des 1-oxadethiacephalosporines
RO83713A (fr) Procede pour la preparation des haloacylamides
BE856029A (fr) Procede ameliore pour la preparation de dithionite de sodium
RO75074A (fr) Procede pour la preparation des thiophenoles
RO81525A (fr) Procede pour la preparation des 9-fluor-prednisolones
RO74147A (fr) Procede pour la preparation des triazolothienodiazepin-1-ones
PT66065A (fr) Procede pour la preparation de hydrocarbonetes

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0079

CCPV Grant of a supplementary protection certificate

Free format text: 093C0079, EXPIRES 20020701

RE20 Patent expired

Owner name: ASTRA LAKEMEDEL A.B.

Effective date: 19970701